1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multimodal integration of radiology, pathology, and genomics for prediction of response to PD-1 blockade in patients with non-small cell lung cancer
    Meeting Abstract

    Luo, J.; Vanguri, R. S.; Aukerman, A. T.; Egger, J. V.; Fong, C. J.; Horvat, N.; Pagano, A.; Araujo-Filho, J.; Geneslaw, L.; Rizvi, H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The effect of tumor size on nodal disease burden in clinically node negative breast cancer
    Meeting Abstract

    Lee, M. K.; Rubenstein, R.; Sevilimedu, V.; Montagna, G.; Shamsunder, M.; Nelson, J. A.; Le, T.; Garcia, P.; Morrow, M.; Tadros, A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Oral minoxidil for the treatment of late alopecia in cancer survivors
    Meeting Abstract

    Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K.; Pan, A.; Dusza, S. W.; Kraehenbuehl, L.; Gajria, D.; Lake, D. E.; Bromberg, J.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Myeloma developing regimens using genomics (MyDRUG) trial: Results from the RAS mutation targeting arm
    Meeting Abstract

    Kumar, S.; Bianchi, G.; Biran, N.; Hultcrantz, M.; Richter, J. R.; Vij, R.; Ye, J. C.; Zonder, J. A.; DiLello, L.; Yesil, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Effectiveness of adjuvant chemoradiotherapy for oral cavity squamous cell carcinoma with minor and major extranodal extension: A multi-institutional consortium study
    Meeting Abstract

    Kolarski, M. M.; Su, J.; Weinreb, I.; Perez-Ordonez, B.; Patel, S. G.; Valero, C.; Xu, B.; Katabi, N.; Clark, J.; Low, T. H. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
    Meeting Abstract

    Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Gundem, G.; Ossa, J. E. A.; Bouvier, N.; Dela Cruz, F. S.; Hameed, M.; Bender, J. L. G.; Tap, W. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC
    Meeting Abstract

    Khaleel, S. S.; Liu, M.; Kuo, F.; Kotecha, R.; Lee, C. H.; Voss, M. H.; Motzer, R. J.; Hakimi, A. A.; Reznik, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Open-label, dose-escalation, and expansion trial of CA-4948 in combination with ibrutinib in patients with relapsed or refractory hematologic malignancies
    Meeting Abstract

    Joffe, E.; Nowakowski, G. S.; Tun, H. W.; Rosenthal, A. C.; Lunning, M. A.; Ramchandren, R.; Li, C. C.; Zhou, L.; Martinez, E.; Von Roemeling, R. W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma: DREAMM-14
    Meeting Abstract

    Hultcrantz, M.; Kleinman, D.; Ghataorhe, P.; McKeown, A.; He, W.; Ling, T.; Jewell, R. C.; Byrne, J.; Eliason, L.; Scott, E. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save